IJzerman AP - Search Results

1

Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP. Heitman LH, et al. Among authors: ijzerman ap. Br J Pharmacol. 2006 Mar;147(5):533-41. doi: 10.1038/sj.bjp.0706655. Br J Pharmacol. 2006. PMID: 16444290 Free PMC article.

2

The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptor.

Garritsen A, Beukers MW, IJzerman AP, Cragoe EJ Jr, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Neurochem Int. 1992 Feb;20(2):207-13. doi: 10.1016/0197-0186(92)90169-r. Neurochem Int. 1992. PMID: 1304860

3

Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

IJzerman AP, Van Galen PJ, Jacobson KA. IJzerman AP, et al. Drug Des Discov. 1992;9(1):49-67. Drug Des Discov. 1992. PMID: 1457698 Free PMC article.

4

Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphics.

Van der Wenden EM, Van Galen PJ, IJzerman AP, Soudijn W. Van der Wenden EM, et al. Among authors: ijzerman ap. Eur J Pharmacol. 1991 Apr 25;206(4):315-23. doi: 10.1016/0922-4106(91)90116-y. Eur J Pharmacol. 1991. PMID: 1915591

5

Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain.

Garritsen A, Ijzerman AP, Beukers MW, Cragoe EJ Jr, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Biochem Pharmacol. 1990 Aug 15;40(4):827-34. doi: 10.1016/0006-2952(90)90323-d. Biochem Pharmacol. 1990. PMID: 2143655

6

Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.

Garritsen A, Ijzerman AP, Beukers MW, Soudijn W. Garritsen A, et al. Among authors: ijzerman ap. Biochem Pharmacol. 1990 Aug 15;40(4):835-42. doi: 10.1016/0006-2952(90)90324-e. Biochem Pharmacol. 1990. PMID: 2143656

7

Mapping the N6-region of the adenosine A1 receptor with computer graphics.

Van Galen PJ, Leusen FJ, IJzerman AP, Soudijn W. Van Galen PJ, et al. Among authors: ijzerman ap. Eur J Pharmacol. 1989 Mar 7;172(1):19-27. doi: 10.1016/0922-4106(89)90041-2. Eur J Pharmacol. 1989. PMID: 2714369

8

Influence of the molecular structure of N6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity.

Pirovano IM, IJzerman AP, Van Galen PJ, Soudijn W. Pirovano IM, et al. Among authors: ijzerman ap. Eur J Pharmacol. 1989 May 11;172(2):185-93. doi: 10.1016/0922-4106(89)90009-6. Eur J Pharmacol. 1989. PMID: 2767141

9

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

Mathôt RA, Gubbens-Stibbe JM, Soudijn W, Jacobson KA, Ijzerman AP, Danhof M. Mathôt RA, et al. Among authors: ijzerman ap. J Pharmacol Exp Ther. 1995 Oct;275(1):245-53. J Pharmacol Exp Ther. 1995. PMID: 7562557 Free PMC article.

10

Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.

van der Wenden EM, von Frijtag Drabbe Künzel JK, Mathôt RA, Danhof M, IJzerman AP, Soudijn W. van der Wenden EM, et al. Among authors: ijzerman ap. J Med Chem. 1995 Sep 29;38(20):4000-6. doi: 10.1021/jm00020a014. J Med Chem. 1995. PMID: 7562934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters